...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: USA ZHCLF investors
Reply New Message
Prev Message Back To Forum Threaded View Next Message

All good point coldnewfie, anyone want give a gander ( Newfy term) why anyone would sell there ZHCLF shares at .15 cents,  my guess , fed of of long  timeline to exist from this investment.  IMO just a few more years or less  and assuming the trials have above 30% ORR  and I think ZCC get money close to Constelaltion phrma or more $1.8 USD billion 

2 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply